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Introduction
Patent ductus arteriosus (PDA), defined as an arterial con-
nection between the pulmonary artery and the aorta, is a com-
mon congenital cardiac defect. The connection can be closed 
surgically or by transcatheter methods. The overall incid-
ence of PDA in infants born prematurely is about 16 times 
higher than that in full term infants. Preterm infants with sym-
ptomatic heart failure secondary to persistent PDA can be tr-
eated by surgical ligation or by conservative treatment involv-
ing indomethacin or ibuprofen. The latter, more conservative 
approach, is usually the treatment of choice due to the risks 
involved with surgical ligation in premature babies.1)2) 
Transcatheter techniques for PDA closure have been ev-
olving for over 40 years, and most PDAs can be safely closed 
in the laboratory setting using currently available coils and de-
vices. Transcatheter closure of the ductus has been effective, 
with shorter hospital stay and lower cost compared to surgical 
closure.2)3) 
Surgical Versus Transcatheter Closure: 
Clinical Outcome and Complications
The first successful surgical closure of PDA was described 
in 1939.4) For several decades it remained as the only practical 
procedure of closing the patent arterial duct.5) The next im-
portant modification in the surgical approach occurred in 
1991, when duct closure was achieved by video assisted tho-
racoscopic (VAT) surgery.6)7) VAT ligation is a minimally in-
vasive method that can be safely performed in children.6)7) 
After surgery, residual shunts occur in approximately 0.6-5% 
of cases.8) Closure of the relatively large, hemodynamically 
significant, PDA may be established as the standard of care, 
and can be performed safely and effectively using either sur-
gical or transcatheter intervention. The appropriate manage-
ment of the very small, hemodynamically insignificant PDA 
is less clear.8)9) In asymptomatic patients with a small duct, the 
only argument in favor of closure is avoiding the risk of de-
veloping endarteritis and endocarditis. This risk has been 
estimated at 0.45% per patient year. However, this figure may 
be high, given the recent report no instances of endarteritis 
in a patient population.8) Routine closure of such defects has 
been advocated to eliminate or reduce the risk of infective 
endocarditis. However, the risk of endocarditis or endarteri-
tis in patients with a small PDA appears to be extremely low, 
and these infections are treatable. Although closure of the 
small duct is generally safe and technically successful, it is 
unknown whether this treatment truly improves the risk ver-
sus benefit balance compared with careful observation. Clo-
sure of a residual PDA to prevent infectious arteritis is strong-
ly recommended despite of silent ductus.9)
Identification and location of the residual duct with com-
plex anatomy remains as a challenge. Surgical ligation of PDA 
can cause the residual duct to adopt a long, distorted tubular 
shape. Real-time, three-dimensional echocardiogram can be 
successful as a means of guidance in the identification of com-
plex residual ducts.10) 
In one reported case,11) several transcatheter approaches 
and coils were utilized for successful transcatheter closure of 
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residual post-surgical PDA. Antegrade (trans-pulmonary) 
or retrograde (trans-aortic) approaches using a snare techni-
que were tried so that catheters with coils such as Nit-Occlud 
(Pfm, Cologne, Germany) were introduced to residual ductus 
with tortuous anatomy after ligation. Also, an antegrade (tr-
ans-aortic) approach for the Gianturco coil and Cook Deta-
chable coil (Cook Cardiology, Bloomington, IN, USA) was 
used for transcatheter closure.2)11-15) 
Catheter-derived therapies had already begun as an alterna-
tive therapy of the surgical approach after 1971. These surgical 
or catheter-derived techniques became complementary for 
PDA closure at that time.2)3)15) The percutaneous embolization 
of coils has been used for smaller ducts, with larger ducts ad-
dressed by open thoracotomy or, occasionally, video assisted 
ligation at that time. 
The potential causes of morbidity after transcatheter coil-
mediated closure of PDA include device embolization, obst-
ruction of the pulmonary arteries or the thoracic aorta, per-
sistence of the residual shunt and hemolysis. Immediate resi-
dual shunt is very common during transcatheter coil-mediat-
ed closure of PDA, with an incidence ranging from 32-42%.2)8)14) 
Although the majority of patients with residual shunts spon-
taneous closure of the PDAs occurs within 36 months, a few 
patients with residual PDA will require a second procedure to 
close the shunt due to hemolysis. The reported incidence of 
hemolysis ranged from 1.0-3.6%.2)8)14) Several types of coils, 
such as Gianturco embolization coils, detachable coils (Cook 
Cardiology), and the Duct-Occlud (Pfm) have proven to be 
both safe and effective in the closure of small-to-moderate 
sized PDAs. The incidence of hemolysis for ductus >3 mm in 
diameter, occurring due to incomplete closure, can be up to 
18.8%. Hemolysis is typically noted within 24 hours after the 
procedure, and can sometimes persist from weeks to months 
after the intervention. Once hemolysis has occurred, severe an-
emia or renal failure may follow.2)8)14) In one study,15) patients 
with a continuous high velocity residual shunt required treat-
ment with a second device after a mean duration of 2 years. 
Transcatheter PDA occlusion remains as a challenge, par-
ticularly in tubular ductus or in infants with large PDA. Even 
though an amplatzer duct occlude (ADO) can be successfully 
implanted, protrusion of the retention disk into the aorta can 
be problematic in infants. To alleviate this problem, modifi-
cations of the ADO device have been developed. These in-
clude an angled ADO device (for infants) or ADO II device 
(for tubular type). The Amplatzer Vascular Plug (AVP) II 
device can be used for closure of ductus in small infants. Both 
the ADO II and AVP II devices have a central plug portion 
sandwiched by two outer disks.3)
In the current era, transcatheter closure is the therapy of ch-
oice for PDA. The remaining indications for surgical inter-
vention are in premature babies, sometimes for closure of 
huge, aneurysmal, infected or complicated ducts that are un-
suitable to accommodate devices, and after complications ari-
sing during a trial of intervention.16)
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